Literature DB >> 11964079

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth.

Thomas Wirth1, Edlyn Soeth, Frank Czubayko, Hartmut Juhl.   

Abstract

It has been suggested that carcinoembryonic antigen (CEA) enhances metastatic seeding of colon cancer cells due to its homo- and heterophilic binding properties. Our recent finding that endogenous CEA protects colon cancer cells against apoptosis suggests a more complex role of CEA in cancer progression. In this study we compared the in vitro effects of endogenous CEA on tumor cell aggregation and cell cycle regulation of human HT29 colon cancer cells with the corresponding in vivo effects, i.e. tumor cell seeding and formation of metastatic lesions. Stable expression of CEA targeted ribozymes (Rz) under control of a tet-off promoter system allowed regulation of CEA levels on the mRNA and protein level by 50%. Downregulation of CEA levels inhibited tumor cell aggregation by 70%. In accordance with previous studies, reduction of CEA levels increased in vitro the apoptotic rate and reduced colony formation by 30% to 50%. To determine the in vivo effect of CEA-dependent aggregate formation and its growth regulating role under apoptotic stress, HT29 cells with high and low CEA levels, respectively, were injected into nude mice. Immunostaining of lung microsections revealed similar numbers of tumor cells one hour after injection. 24 h later virtually all cells were removed from the lung in both groups. However, after 6 weeks all doxycycline treated mice (Rz off = CEA high) showed 14.5 +/- 4.6 metastatic lung lesions/mouse while 0.2 +/- 0.2 lesions/mouse appeared in the untreated group (Rz on = CEA low) (P < 0.001). Our study demonstrates a multifunctional role of CEA and indicates a prometastatic role of CEA independent of its adhesive function possibly due to its anti-apoptotic function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964079     DOI: 10.1023/a:1014566127493

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  15 in total

1.  Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9.

Authors:  Giulia Roda; Stephanie Dahan; Laura Mezzanotte; Alessandra Caponi; Franziska Roth-Walter; David Pinn; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2009-07-27       Impact factor: 5.325

2.  Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients.

Authors:  Shi Chen; Ying-Bo Chen; Yuan-Fang Li; Xing-Yu Feng; Zhi-Wei Zhou; Xiu-Hong Yuan; Chao-Nan Qian
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 3.  Sry-box (Sox) transcription factors in gastrointestinal physiology and disease.

Authors:  A D Gracz; S T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-03       Impact factor: 4.052

4.  Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.

Authors:  Bo Jin; Yu Dong; Hui-min Wang; Jin-su Huang; Bao-hui Han
Journal:  Acta Pharmacol Sin       Date:  2014-02-03       Impact factor: 6.150

5.  CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients.

Authors:  Francesco Facchinetti; Raffaella Aldigeri; Rosalia Aloe; Beatrice Bortesi; Andrea Ardizzoni; Marcello Tiseo
Journal:  Tumour Biol       Date:  2015-03-03

6.  Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.

Authors:  Matthew R Dallas; Guosheng Liu; Wei-Chiang Chen; Susan N Thomas; Denis Wirtz; David L Huso; Konstantinos Konstantopoulos
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

7.  The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR-TKIs but is not an indication of acquired resistance to EGFR-TKIs in NSCLC patients with EGFR mutationsm.

Authors:  Jingquan Han; Yuzhang Li; Shouqiang Cao; Qing Dong; Guibin Zhao; Xiangyu Zhang; Jian Cui
Journal:  Biomed Rep       Date:  2017-05-19

8.  Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Authors:  Te-Wei Chu; Jindřich Kopeček
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

9.  A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Authors:  Madeeha Aqil; Kim M Elseth; Ashok Arjunakani; Philip Nebres; Courtney P Amegashie; Devang H Thanki; Premal B Desai; James A Radosevich
Journal:  Tumour Biol       Date:  2014-12-11

Review 10.  The Sox transcriptional factors: Functions during intestinal development in vertebrates.

Authors:  Liezhen Fu; Yun-Bo Shi
Journal:  Semin Cell Dev Biol       Date:  2016-08-25       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.